Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.

Koppel J, Sunday S, Goldberg TE, Davies P, Christen E, Greenwald BS; Alzheimer's Disease Neuroimaging Initiative..

Am J Geriatr Psychiatry. 2014 Jul;22(7):698-707. doi: 10.1016/j.jagp.2012.10.028.

PMID:
23672944
2.

Psychosis in Alzheimer's disease.

Murray PS, Kumar S, Demichele-Sweet MA, Sweet RA.

Biol Psychiatry. 2014 Apr 1;75(7):542-52. doi: 10.1016/j.biopsych.2013.08.020. Review.

3.

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Shen L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative..

Alzheimers Dement. 2013 Sep;9(5):e111-94. doi: 10.1016/j.jalz.2013.05.1769. Review.

4.

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative..

Alzheimers Dement. 2012 Feb;8(1 Suppl):S1-68. doi: 10.1016/j.jalz.2011.09.172. Review.

5.

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.

Chen Z, Zhong C.

Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Review.

6.

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Green RC, Harvey D, Jack CR, Jagust W, Luthman J, Morris JC, Petersen RC, Saykin AJ, Shaw L, Shen L, Schwarz A, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative..

Alzheimers Dement. 2015 Jun;11(6):e1-120. doi: 10.1016/j.jalz.2014.11.001. Review.

PMID:
26073027
7.

[Current topics about mild cognitive impairment (MCI)].

Yamamoto Y.

Seishin Shinkeigaku Zasshi. 2011;113(6):584-92. Review. Japanese.

PMID:
21815470
8.

FDG-PET Contributions to the Pathophysiology of Memory Impairment.

Segobin S, La Joie R, Ritz L, Beaunieux H, Desgranges B, Chételat G, Pitel AL, Eustache F.

Neuropsychol Rev. 2015 Sep;25(3):326-55. doi: 10.1007/s11065-015-9297-6. Review.

PMID:
26319237
9.

Applications of neuroimaging to disease-modification trials in Alzheimer's disease.

Fleisher AS, Donohue M, Chen K, Brewer JB, Aisen PS; Alzheimer's Disease Neuroimaging Initiative..

Behav Neurol. 2009;21(1):129-36. doi: 10.3233/BEN-2009-0241. Review.

10.
11.

Memory suppression in Alzheimer's disease.

El Haj M.

Neurol Sci. 2016 Mar;37(3):337-43. doi: 10.1007/s10072-015-2441-5. Review.

PMID:
26700801
12.

Genetics of cognitive control: Implications for Nimh's research domain criteria initiative.

Glahn DC, Knowles EE, Pearlson GD.

Am J Med Genet B Neuropsychiatr Genet. 2016 Jan;171B(1):111-20. doi: 10.1002/ajmg.b.32345. Review.

PMID:
26768522
13.

Genetics of psychosis of Alzheimer disease.

Shah C, DeMichele-Sweet MA, Sweet RA.

Am J Med Genet B Neuropsychiatr Genet. 2017 Jan;174(1):27-35. doi: 10.1002/ajmg.b.32413. Review.

Items per page

Supplemental Content

Support Center